ImageneBio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImageneBio and other ETFs, options, and stocks.About IMA
ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life.
CEOKristin Yarema
CEOKristin Yarema
Employees10
Employees10
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2016
Founded2016
Employees10
Employees10
IMA Key Statistics
Market cap67.93M
Market cap67.93M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume57.52K
Average volume57.52K
High today$5.88
High today$5.88
Low today$5.75
Low today$5.75
Open price$5.80
Open price$5.80
Volume30.08K
Volume30.08K
52 Week high$20.40
52 Week high$20.40
52 Week low$5.75
52 Week low$5.75
Stock Snapshot
The current ImageneBio(IMA) stock price is $5.80, with a market capitalization of 67.93M. The stock trades at a price-to-earnings (P/E) ratio of -0.72.
As of 2025-12-28, ImageneBio(IMA) stock has fluctuated between $5.75 and $5.88. The current price stands at $5.80, placing the stock +0.9% above today's low and -1.4% off the high.
ImageneBio(IMA) shares are trading with a volume of 30.08K, against a daily average of 57.52K.
In the last year, ImageneBio(IMA) shares hit a 52-week high of $20.40 and a 52-week low of $5.75.
In the last year, ImageneBio(IMA) shares hit a 52-week high of $20.40 and a 52-week low of $5.75.
People also own
Based on the portfolios of people who own IMA. This list is generated using Robinhood data, and it’s not a recommendation.